Published: 2019 April 09
Updated : 2022 July 05

Pediatric Clinical Trails Market Size, Competitive Landscape and Market Forecast - 2029

SKU : PH217
180 pages
Report Summary
Table of Contents

Global Pediatric Clinical Trials Market is segmented By Phases (Phase I, Phase II, Phase III, Phase IV), By Design (Treatment Studies, Observational Studies (Prospective Cohort, Case-Control Study, Cohort Study, Cross-Sectional Study, Ecological Study) ), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2022-2029


Market Overview

The Global Pediatric Clinical Trials Market is expected to grow at a high CAGR during the forecasting period (2022-2029).

Market Growth

According to FDA stats, nearly 60% of the drugs used for children were not approved for pediatric use. This situation is increasing the demand for the global pediatric clinical trials.

“Rising chronical pediatric diseases upsurge the demand for pediatric clinical trials.”

  • In recent years, instances of chronical diseases like Asthma, Diabetes, Cerebral palsy, Sickle cell anemia, Cystic fibrosis, Cancer, AIDS, Epilepsy, Congenital heart problems, etc., have become common in children. According to the National Institutes of Health, 70% of the medicines given to children for these diseases have only been tested in adults.
  • However, new regulatory policies of the FDA and EMEA for approved and investigational drugs for children are raising the need for the medications with customized dosages as per the age groups. As per the stats of the U.S. FDA, as of February 2017, a total of 935 pediatric study requests were received. All of these scenarios are driving the global market for Pediatric Clinical trials.
  • Also, the outburst of infectious diseases like Dengue, Cholera, etc., is increasing the demand for the pediatric clinical trials market across the globe.

 Market Regional Insights

  • The report segments the geographies by regions, which include North America, South America, Europe, Asia Pacific, and RoW.
  • North America is taking a significant share of the market with a significant contribution from the US, followed by Europe and the Asia Pacific. As per the studies from The Office of Pediatric Therapeutics (OPT), around 86% of pediatric clinical trials out of 346 clinical trials are done by US companies alone.
  • Increasing Diabetic cases in children, mainly in the US, tremendous growth in pediatric clinical research in the region, various transformative initiatives by The Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA) like encouraging the research and development of drugs by offering both incentives and obligations to the companies are mainly driving the growth in these region.

Scope of this report

  • The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
  • Global Pediatric Clinical Trials Market is segmented based on Phases such as Phase I, Phase II, Phase III, Phase IV. Also, the market is classified based on the design as Treatment Studies (further organized as Randomized Control Trial, Adaptive Clinical Trial, and Non-Randomized Control Trial) and Observational Studies (also classified as Prospective Cohort, Case-Control Study, Cohort Study, Cross-Sectional Study, and Ecological Study).
  • The report profiles the following companies, which includes Quintiles, Parexel, Pharmaceutical Product Development LLC, Covance Inc., Pfizer Inc, CenterWatch, Paidion Research, Inc., and Duke Clinical Research Institute

Trending Topics

Pediatric Vaccines Market

Pediatric Catheters Market

Pediatric Ventilators Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy